Search Results

Silicone Tissue Expanders are intended for temporary subcutaneous implantation to develop surgical flaps Diffective rissue coverage required in a wide variety of applications, particularly to aid in and addition following mastectomy, to aide in the treatment of underdeveloped breasts and to aid treatment of soft tissue deformities.

Not Found

The provided text is a 510(k) clearance letter from the FDA for "Silicone Tissue Expanders" (K070303). This document confirms that the device is substantially equivalent to legally marketed predicate devices and outlines the indications for use.

However, this document does not contain any information regarding acceptance criteria or a study proving the device meets acceptance criteria.

The FDA 510(k) clearance process primarily focuses on demonstrating substantial equivalence to a predicate device, meaning it is as safe and effective as a legally marketed device. It does not typically require the submission of detailed performance studies with acceptance criteria in the same way a PMA (Premarket Approval) application would.

Therefore, I cannot populate the requested table or provide information on the study design, sample sizes, ground truth establishment, or expert involvement as this information is not present in the provided text.

To address your request, I would need a different type of document, such as a summary of safety and effectiveness data, a clinical study report, or a comprehensive premarket submission that includes performance testing and clinical data.

Ask a specific question about this device